199 related articles for article (PubMed ID: 16582106)
41. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
42. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter.
Chen H; Zhang P; Radomska HS; Hetherington CJ; Zhang DE; Tenen DG
J Biol Chem; 1996 Jun; 271(26):15743-52. PubMed ID: 8663022
[TBL] [Abstract][Full Text] [Related]
43. Spi-1 and Spi-B control the expression of the Grap2 gene in B cells.
Garrett-Sinha LA; Hou P; Wang D; Grabiner B; Araujo E; Rao S; Yun TJ; Clark EA; Simon MC; Clark MR
Gene; 2005 Jun; 353(1):134-46. PubMed ID: 15936902
[TBL] [Abstract][Full Text] [Related]
44. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.
Schubart DB; Rolink A; Schubart K; Matthias P
J Immunol; 2000 Jan; 164(1):18-22. PubMed ID: 10604987
[TBL] [Abstract][Full Text] [Related]
45. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.
Qin XF; Reichlin A; Luo Y; Roeder RG; Nussenzweig MC
EMBO J; 1998 Sep; 17(17):5066-75. PubMed ID: 9724642
[TBL] [Abstract][Full Text] [Related]
46. The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1.
Tiedt R; Bartholdy BA; Matthias G; Newell JW; Matthias P
EMBO J; 2001 Aug; 20(15):4143-52. PubMed ID: 11483517
[TBL] [Abstract][Full Text] [Related]
47. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
[TBL] [Abstract][Full Text] [Related]
48. Knockout B lymphoma cell lines as biochemical tools to explore multiple signalling pathways.
Veale MF; Dietrich WM; Corcoran LM
Immunol Cell Biol; 2003 Aug; 81(4):297-304. PubMed ID: 12848851
[TBL] [Abstract][Full Text] [Related]
49. Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation.
Shen Y; Hendershot LM
J Immunol; 2007 Sep; 179(5):2969-78. PubMed ID: 17709512
[TBL] [Abstract][Full Text] [Related]
50. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
Malone CS; Wall R
J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
[TBL] [Abstract][Full Text] [Related]
51. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
[TBL] [Abstract][Full Text] [Related]
52. T Cell Specific BOB.1/OBF.1 Expression Promotes Germinal Center Response and T Helper Cell Differentiation.
Betzler AC; Ezić J; Abou Kors T; Hoffmann TK; Wirth T; Brunner C
Front Immunol; 2022; 13():889564. PubMed ID: 35603192
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
Tang H; Sharp PA
Immunity; 1999 Nov; 11(5):517-26. PubMed ID: 10591177
[TBL] [Abstract][Full Text] [Related]
54. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
McCune RC; Syrbu SI; Vasef MA
Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
[TBL] [Abstract][Full Text] [Related]
55. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment.
Samardzic T; Marinkovic D; Nielsen PJ; Nitschke L; Wirth T
Mol Cell Biol; 2002 Dec; 22(23):8320-31. PubMed ID: 12417733
[TBL] [Abstract][Full Text] [Related]
56. Catfish Oct2 binding affinity and functional preference for octamer motifs, and interaction with OBF-1.
Ross DA; Lyles M; Ledford BE; Magor BG; Wilson MR; Miller NW; Clem LW; Middleton DA; Warr GW
Dev Comp Immunol; 1999 Apr; 23(3):199-211. PubMed ID: 10402207
[TBL] [Abstract][Full Text] [Related]
57. Differential requirement for OBF-1 during antibody-secreting cell differentiation.
Corcoran LM; Hasbold J; Dietrich W; Hawkins E; Kallies A; Nutt SL; Tarlinton DM; Matthias P; Hodgkin PD
J Exp Med; 2005 May; 201(9):1385-96. PubMed ID: 15867091
[TBL] [Abstract][Full Text] [Related]
58. PU.1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase.
Christie DA; Xu LS; Turkistany SA; Solomon LA; Li SK; Yim E; Welch I; Bell GI; Hess DA; DeKoter RP
J Immunol; 2015 Jan; 194(2):595-605. PubMed ID: 25505273
[TBL] [Abstract][Full Text] [Related]
59. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.
Luo Y; Fujii H; Gerster T; Roeder RG
Cell; 1992 Oct; 71(2):231-41. PubMed ID: 1423591
[TBL] [Abstract][Full Text] [Related]
60. Impaired Peyer's patch development in BOB.1/OBF.1-deficient mice.
Betzler AC; Fiedler K; Kokai E; Wirth T; Hoffmann TK; Brunner C
Eur J Immunol; 2021 Jul; 51(7):1860-1863. PubMed ID: 33733501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
